Alphabet Inc. Lyell Immunopharma, Inc. Transaction History
Alphabet Inc.
- $1.46 Billion
- Q3 2024
A detailed history of Alphabet Inc. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 5,865,125 shares of LYEL stock, worth $5.57 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
5,865,125
Previous 5,865,125
-0.0%
Holding current value
$5.57 Million
Previous $8.5 Million
4.83%
% of portfolio
0.55%
Previous 0.54%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
122Shares Held
142MCall Options Held
18.1KPut Options Held
200-
Mwg Management Ltd. Washington, DC20.2MShares$19.2 Million30.81% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$14.3 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$14.3 Million13.96% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$9.57 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $235M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...